AIFA - Allergy and Immunology Foundation of Australasia
Due to the generous support of individuals, families and organisations, $120,000 in AIFA grants were awarded in 2019 at the closing function of the ASCIA 2019 Conference, including grants sponsored by CSL Behring and DBV Technologies. .
For details go to www.allergyimmunology.org.au/projects/#latest
Congratulations to all of the AIFA grant winning chief investigators, who are supported by respected nationwide research teams. We are looking forward to reporting outcomes from this research in years to come.
Thank you to AIFA supporters for making these grants possible, and our independent and voluntary expert grant selection panel who select AIFA research grants each year through a robust selection process.
AIFA is now seeking donations and support for the 2020 grants.
By donating to AIFA, you can be reassured that 100% of donations to AIFA directly fund allergy/immunology research grants.
- All donations of $100 or more are perpetually acknowledged on the AIFA website www.allergyimmunology.org.au/our-supporters/donors
- Significant donors (of $10,000 or more) may request targeted research project funding in particular areas.
AIFA research grants encourage:
- Emerging researchers who may not yet receive grants from the NHMRC or other organisations
- Innovative research that requires seed funding
- Collaborative research projects conducted throughout Australia and New Zealand
- Projects that will translate to better treatment and care for patients with allergy and other immune diseases
AIFA was established in 2013 by ASCIA, the peak professional body for allergy and clinical immunology in Australasia. The aim of AIFA is to improve the health and care of people with allergy and other immune diseases by funding medical research and raising awareness of these disorders in Australia and New Zealand.
Allergy and other immune system disorders (primary immunodeficiencies and autoimmune diseases) are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population. Funding of research into allergy and other immune diseases is vital for the prevention and treatment of these diseases, and to ultimately find cures.
Content updated October 2019